Literature DB >> 22014898

A standardized G2-assay for the prediction of individual radiosensitivity.

Gabriel E Pantelias1, Georgia I Terzoudi.   

Abstract

BACKGROUND AND
PURPOSE: An increased yield of chromatid breaks following G2-phase irradiation could be a marker of radiosensitivity-predisposing genes that respond to DNA damage. We have shown that the dynamic nature of chromatin-nucleoprotein complex, which is capable of rapid unfolding, disassembling, assembling and refolding, affects repair of radiation-induced DNA-lesions and causes chromatid breaks during G2-M transition in damaged DNA sites. Here, we investigate induction and repair kinetics of chromatid breaks, their potential role in radiosensitivity predisposition and a standardized G2-assay is proposed to assess individual radiosensitivity.
MATERIALS AND METHODS: Lymphocytes from 125 blood donors with significant inter-individual radiosensitivity variation (healthy, cancer, AT-patients) are used to correlate G2-checkpoint efficiency with chromatid breakage and individual radiosensitivity. Experiments involve repair kinetics of chromatid breaks using colcemid-block and treatment with caffeine to abrogate G2-checkpoint, generate internal controls and standardize the G2-assay.
RESULTS: Radiation-induced chromatid breaks during G2-M transition, following 4h repair, remained unchanged and a significant correlation between G2-chromosomal radiosensitivity and G2-checkpoint efficiency to prevent chromatid breakage was found. A standardized G2-assay is developed by introducing normalization to conditions reflecting lack of checkpoint and repair similar to those of AT-patients, generating a unique standard for individual radiosensitivity testing.
CONCLUSIONS: The standardized G2-assay can minimize inter-laboratory and intra-experimental variations and may have straightforward application in clinical practice for individualization of radiotherapy protocols. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22014898     DOI: 10.1016/j.radonc.2011.09.021

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Comparing Lymphocyte Radiosensitivity of Prostate Cancer Patients with Healthy Donors Using Micronuclei and Chemical Premature Chromosome Condensation Tests.

Authors:  Golfam F; Hashemi B; Haeri A; Nikoofar A
Journal:  J Biomed Phys Eng       Date:  2020-08-01

2.  Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.

Authors:  Kathleen Claes; Julie Depuydt; A Malcolm R Taylor; James I Last; Annelot Baert; Peter Schietecatte; Veerle Vandersickel; Bruce Poppe; Kim De Leeneer; Marc D'Hooghe; Anne Vral
Journal:  Neuromolecular Med       Date:  2013-04-30       Impact factor: 3.843

3.  Individual Radiosensitivity Assessment of the Families of Ataxia-Telangiectasia Patients by G2-Checkpoint Abrogation.

Authors:  Asghar Aghamohammadi; Seyed M Akrami; Marjan Yaghmaie; Nima Rezaei; Gholamreza Azizi; Mehdi Yaseri; Hassan Nosrati; Majid Zaki-Dizaji
Journal:  Sultan Qaboos Univ Med J       Date:  2019-03-28

4.  Differences in DNA Repair Capacity, Cell Death and Transcriptional Response after Irradiation between a Radiosensitive and a Radioresistant Cell Line.

Authors:  Mireia Borràs-Fresneda; Joan-Francesc Barquinero; Maria Gomolka; Sabine Hornhardt; Ute Rössler; Gemma Armengol; Leonardo Barrios
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

5.  Assessment of Correlation between Chromosomal Radiosensitivity of Peripheral Blood Lymphocytes after In vitro Irradiation and Normal Tissue Side Effects for Cancer Patients Undergoing Radiotherapy.

Authors:  Kamilė Guogytė; Aista Plieskienė; Rima Ladygienė; Žygimantas Vaisiūnas; Olga Sevriukova; Vinsas Janušonis; Julius Žiliukas
Journal:  Genome Integr       Date:  2017-01-23

6.  Individual Radiosensitivity in Oncological Patients: Linking Adverse Normal Tissue Reactions and Genetic Features.

Authors:  Elisa Palumbo; Celeste Piotto; Enrica Calura; Elena Fasanaro; Elena Groff; Fabio Busato; Badr El Khouzai; Michele Rigo; Laura Baggio; Chiara Romualdi; Demetre Zafiropoulos; Antonella Russo; Maddalena Mognato; Luigi Corti
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

7.  G2/M Checkpoint Abrogation With Selective Inhibitors Results in Increased Chromatid Breaks and Radiosensitization of 82-6 hTERT and RPE Human Cells.

Authors:  Aggeliki Nikolakopoulou; Aashish Soni; Martha Habibi; Pantelis Karaiskos; Gabriel Pantelias; Georgia I Terzoudi; George Iliakis
Journal:  Front Public Health       Date:  2021-05-28

8.  Individual radiosensitivity in a breast cancer collective is changed with the patients' age.

Authors:  Judith Auer; Ulrike Keller; Manfred Schmidt; Oliver Ott; Rainer Fietkau; Luitpold V Distel
Journal:  Radiol Oncol       Date:  2014-01-22       Impact factor: 2.991

9.  Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.

Authors:  Annelot Baert; Julie Depuydt; Tom Van Maerken; Bruce Poppe; Fransiska Malfait; Katrien Storm; Jenneke van den Ende; Tim Van Damme; Sylvia De Nobele; Gianpaolo Perletti; Kim De Leeneer; Kathleen B M Claes; Anne Vral
Journal:  Breast Cancer Res       Date:  2016-05-17       Impact factor: 6.466

10.  Individual Radiosensitivity as a Risk Factor for the Radiation-Induced Acute Radiodermatitis.

Authors:  Juras Kišonas; Jonas Venius; Olga Sevriukova; Mindaugas Grybauskas; Daiva Dabkevičienė; Arvydas Burneckis; Ričardas Rotomskis
Journal:  Life (Basel)       Date:  2021-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.